News
Stocktwits on MSN50m
Patient Death In Rocket Pharma Trial Triggers Downgrades, But Retail Traders Bet Big On Strong RecoveryRocket Pharmaceuticals (RCKT) plunged nearly 63% on Tuesday, hitting an all-time low after the U.S. FDA placed a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback